SARS-CoV-2

These novel immune signatures identify patients most at risk for developing severe COVID-19 symptoms.

Lockdown measures not only reduced the number of COVID-19 cases but also resulted in a temporary improvement in air quality, study finds.

Using flow cytometry, researchers have developed a sensitive and specific test for COVID-19 that can identify asymptomatic carriers.

Plant-based ionizers are surprisingly effective at removing aerosols and could play an important role in preventing COVID-19 transmission.

A multifaceted study by the Singapore 2019 Novel Coronavirus Outbreak Research team is filling in some of the gaps left in the urgent quest to understand COVID-19 infection.

A*STAR researchers have developed a point-of-care rapid antibody test kit that can detect antibodies produced in response to SARS-CoV-2 infection in just fifteen minutes.

By eliminating bottlenecks and automating manual processes, the RESOLUTE test kit and RAVE system co-developed by A*STAR scientists will help give COVID-19 testing a much-needed boost.

A*STAR researchers use digital drug simulators to predict the efficacies of repurposed antivirals for treating COVID-19.

This ‘smart mask’ designed by A*STAR researchers may reduce the risk of infection in healthcare workers by enabling remote, real-time monitoring of patients’ symptoms.

Serology testing may be fast and easy to perform, but there are still some limitations that need to be overcome, suggests Laurent Renia.

Antibodies that recognize the SARS-CoV-2 spike protein show potential for diagnosing COVID-19.

The presence of memory T cells in COVID-19-recovered patients hints at their importance in COVID-19 immunity.